The show has dismal reviews and is consistently ranked as one of the worst, if not the worst, of reality television. Erin Lee ...

NPR's Scott Simon talks to the director and producer of "Andre is an Idiot," a new irreverent documentary about one man's battle with terminal colon cancer.

“I got some good news and some bad news,” the Netflix star, 61, said of her biopsy results Jason Mendez/Getty Kelli Finglass said she had five spots on her skin checked before undergoing a cosmetic ...

A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade attack by the body's immune system, a new study shows. Led by researchers at ...

Eddie Vedder is at the heart of Matter of Time, which arrives on Netflix this Monday, February 9, but the new documentary does not focus on the singer’s storied exploits with his band Pearl Jam.

Incidence is increasing faster than melanoma, with typical presentation in the mid-70s and risk amplified by UV exposure, fair skin, immunosuppression, and MCPyV-associated oncogenesis. Accurate ...

There are three common types of skin cancer in the United States: basal cell carcinoma, squamous cell carcinoma and melanoma. Merkel cell carcinoma is a rare type of skin cancer. Fred Hutch Cancer ...

81 years ago today, Bob Marley, the Jamaican musician and outspoken social advocate, was born. While many know his accomplishments in music, culture, and society, less know that his untimely passing ...

For Sun Pharma, every day—from Super Bowl Sunday and beyond—is “SUNday.” That’s the premise of a new unbranded campaign the drugmaker is rolling out amid the big game on Feb. 8, joining peers like ...

Michelle Monaghan is getting candid about her battle with a serious form of skin cancer. Monaghan, 49, exclusively opened up to Us Weekly about being diagnosed with melanoma, after not being aware of ...

A breakthrough personalized mRNA cancer vaccine that trains the immune system to target patients' unique tumor mutations is showing promising results. Five-year trial data show the risk of recurrence ...

More than 8500 people are expected to die from melanoma in the US in 2026. Early detection dramatically improves survival, yet the tools for identifying suspicious lesions remain, well, cumbersome.